Uab Medicine Auth-B1 (al Uabgen 5 09/01/2030)
13F holders, Q2 2026 (June 30)1holders
$1.03avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Uab Medicine Auth-B1 (al Uabgen 5 09/01/2030) in their 13F filings. The largest holder was Park Place Capital Corp ($26K).
- Company
- Uab Medicine Auth-B1 (al Uabgen 5 09/01/2030)
- CUSIP
- 902562BV8
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $26K |
| Exits | 0 | $0 |
Ownership 1 holders
| Park Place Capital Corp | 0.00% | New | 25,000 | $26K |
"% of holder's portfolio" is UAB MEDICINE AUTH-B1 (AL UABGEN 5 09/01/2030)'s weight in each manager's 13F, not the share of Uab Medicine Auth-B1 (al Uabgen 5 09/01/2030) the manager owns.